The weed wire Psychedelic treatment firm enters NIH research deal CaaMTech will be researching synthetic tryptamine-based compounds as part of a cooperative R&D program Nick LabaMay 7, 2020
News Psychedelic conference weighs treatment efficacy against mainstream viability Medical and therapeutic benefits are clear even if scalability isn't Michelle GamageApril 16, 2020
CBD Little buds to watch: OTC Stock Review features 4 CBD stock picks General Cannabis Corp. saw its shares climb over 30 per cent Thursday Nick LabaNovember 21, 2019